InvestorsHub Logo
Followers 10
Posts 1578
Boards Moderated 0
Alias Born 10/15/2014

Re: None

Friday, 11/10/2017 5:08:31 PM

Friday, November 10, 2017 5:08:31 PM

Post# of 16885
One last thought...you don't have to be a weatherman to know which way the wind blows.

It won't be the payout I dreamed of, but I should at least be able to make my investment back and with a (small) profit.


Rubin: “We are evaluating alternatives and potential pathways available to us including ex-U.S. partnering opportunities for Probuphine, possible collaborations for one or more of our ProNeura programs and financing strategies. Importantly, I want to assure you that in addition to these alternatives that I just mentioned and in addition to our discussions with Braeburn and with treatment providers that are aimed at a fuller understanding of the impediments to the uptake of Probuphine, the Board is actively assessing all operative and strategic business options available that can increase shareholder value. We will keep you informed.”

Bhonsle: “Although we can’t go into all the details right now, I want to assure you that the Board and management are looking at all options for maximizing the value of Titan, both from the product portfolio and other strategic considerations. We look forward to reporting continued progress as we move forward.”
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TTNP News